Passage Bio, INC. (PASG) SEC Filings — 2024

Filings

• Passage Bio, INC. SC 13G Filing — SC 13G · Nov 14, 2024
• Passage BIO, Inc. Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
• Passage BIO Files 8-K — 8-K · Oct 24, 2024
• Passage BIO, Inc. Files 8-K Report — 8-K · Sep 16, 2024
• Passage BIO Appoints New CMO and Board Member — 8-K · Sep 10, 2024
• Passage BIO Reports Material Impairment — 8-K · Sep 6, 2024
• Versant Venture Capital VI Amends Passage BIO Stake — SC 13D/A · Aug 9, 2024
• Passage Bio, INC. SC 13G/A Filing — SC 13G/A · Aug 9, 2024
• Passage BIO Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
• Passage BIO Faces Delisting Notice — 8-K · Aug 2, 2024
• Passage BIO, Inc. Files 8-K: Material Agreement, Financials, Officer Changes — 8-K · Aug 1, 2024
• Passage BIO Files 8-K — 8-K · Jul 16, 2024
• Versant Venture Capital VI Amends Passage BIO Stake — SC 13D/A · May 29, 2024
• Passage BIO Reports on Shareholder Vote Matters — 8-K · May 22, 2024
• Passage BIO, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
• OrbiMed Amends Passage BIO Stake Filing — SC 13D/A · Apr 12, 2024
• Passage Bio Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 9, 2024
• Passage Bio, INC. SC 13G Filing — SC 13G · Mar 29, 2024
• Passage BIO, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 4, 2024
• New Mountain Capital to Acquire Passage BIO for $1.4B — 8-K · Feb 29, 2024
• Passage Bio, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Passage BIO Confirms Nasdaq Listing for Common Stock — 8-K · Jan 5, 2024